
David J. Steadman
Examiner (ID: 6795, Phone: (571)272-0942 , Office: P/1656 )
| Most Active Art Unit | 1656 |
| Art Unit(s) | 1656, 1652 |
| Total Applications | 1737 |
| Issued Applications | 740 |
| Pending Applications | 242 |
| Abandoned Applications | 766 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17577008
[patent_doc_number] => 20220133863
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => TREATMENT OF SANFILIPPO SYNDROME TYPE B
[patent_app_type] => utility
[patent_app_number] => 17/350909
[patent_app_country] => US
[patent_app_date] => 2021-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29032
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17350909
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/350909 | TREATMENT OF SANFILIPPO SYNDROME TYPE B | Jun 16, 2021 | Abandoned |
Array
(
[id] => 17274813
[patent_doc_number] => 20210381011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => YEAST CELLS HAVING REDUCTIVE TCA PATHWAY FROM PYRUVATE TO SUCCINATE AND OVEREXPRESSING AN EXOGENOUS NAD(P+) TRANSHYDROGENASE ENZYME
[patent_app_type] => utility
[patent_app_number] => 17/348363
[patent_app_country] => US
[patent_app_date] => 2021-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17358
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17348363
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/348363 | Yeast cells having reductive TCA pathway from pyruvate to succinate and overexpressing an exogenous NAD(P+) transhydrogenase enzyme | Jun 14, 2021 | Issued |
Array
(
[id] => 20896619
[patent_doc_number] => 12703877
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-08-11
[patent_title] => Methods and systems to secrete lignin-modifying enzymes and uses thereof
[patent_app_type] => utility
[patent_app_number] => 18/000797
[patent_app_country] => US
[patent_app_date] => 2021-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 2345
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18000797
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/000797 | Methods and Systems to Secrete Lignin-Modifying Enzymes and Uses Thereof | Jun 6, 2021 | Pending |
Array
(
[id] => 18537817
[patent_doc_number] => 20230242919
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => ENZYMES AND REGULATORY PROTEINS IN TRYPTAMINE METABOLISM
[patent_app_type] => utility
[patent_app_number] => 18/000931
[patent_app_country] => US
[patent_app_date] => 2021-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30596
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18000931
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/000931 | ENZYMES AND REGULATORY PROTEINS IN TRYPTAMINE METABOLISM | Jun 3, 2021 | Pending |
Array
(
[id] => 18027254
[patent_doc_number] => 11510413
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-29
[patent_title] => Lipolytic enzyme for use in baking
[patent_app_type] => utility
[patent_app_number] => 17/337613
[patent_app_country] => US
[patent_app_date] => 2021-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13535
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17337613
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/337613 | Lipolytic enzyme for use in baking | Jun 2, 2021 | Issued |
Array
(
[id] => 17370289
[patent_doc_number] => 20220025341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => MINIMAL PEPTIDE FUSIONS FOR TARGETED INTRACELLULAR PROTEIN DEGRADATION
[patent_app_type] => utility
[patent_app_number] => 17/334055
[patent_app_country] => US
[patent_app_date] => 2021-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4963
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17334055
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/334055 | MINIMAL PEPTIDE FUSIONS FOR TARGETED INTRACELLULAR PROTEIN DEGRADATION | May 27, 2021 | Pending |
Array
(
[id] => 17982947
[patent_doc_number] => 20220348983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => OPLOPHORUS-DERIVED LUCIFERASES, NOVEL COELENTERAZINE SUBSTRATES, AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/332459
[patent_app_country] => US
[patent_app_date] => 2021-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56996
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17332459
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/332459 | Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use | May 26, 2021 | Issued |
Array
(
[id] => 17243822
[patent_doc_number] => 20210363565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => ENHANCEMENT OF KINASE TARGET ENGAGEMENT
[patent_app_type] => utility
[patent_app_number] => 17/327319
[patent_app_country] => US
[patent_app_date] => 2021-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14165
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17327319
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/327319 | ENHANCEMENT OF KINASE TARGET ENGAGEMENT | May 20, 2021 | Abandoned |
Array
(
[id] => 17414261
[patent_doc_number] => 20220049165
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => BREVIBACILLUS AGRI, PREPARATION THEREOF, METHOD FOR PREPARING SURFACTANT AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/317812
[patent_app_country] => US
[patent_app_date] => 2021-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7639
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17317812
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/317812 | None | May 10, 2021 | Issued |
Array
(
[id] => 17185507
[patent_doc_number] => 20210332392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => COMPOSITIONS AND METHODS OF USE THEREOF FOR SCANDIUM SEPARATION FROM RARE EARTH CONTAINING MATERIAL
[patent_app_type] => utility
[patent_app_number] => 17/240794
[patent_app_country] => US
[patent_app_date] => 2021-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25732
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17240794
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/240794 | COMPOSITIONS AND METHODS OF USE THEREOF FOR SCANDIUM SEPARATION FROM RARE EARTH CONTAINING MATERIAL | Apr 25, 2021 | Pending |
Array
(
[id] => 19164326
[patent_doc_number] => 11980207
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-14
[patent_title] => Recombinant components and compositions for use in food products
[patent_app_type] => utility
[patent_app_number] => 17/239325
[patent_app_country] => US
[patent_app_date] => 2021-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 14
[patent_no_of_words] => 32930
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17239325
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/239325 | Recombinant components and compositions for use in food products | Apr 22, 2021 | Issued |
Array
(
[id] => 18406044
[patent_doc_number] => 20230167395
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => THERMOSTABLE PHYTASE FOR LOW SODIUM STARCH LIQUEFACTION
[patent_app_type] => utility
[patent_app_number] => 17/916652
[patent_app_country] => US
[patent_app_date] => 2021-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1703
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17916652
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/916652 | THERMOSTABLE PHYTASE FOR LOW SODIUM STARCH LIQUEFACTION | Apr 19, 2021 | Abandoned |
Array
(
[id] => 18364138
[patent_doc_number] => 20230145729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => INDOLE DITERPENE BIOSYNTHESIS
[patent_app_type] => utility
[patent_app_number] => 17/995191
[patent_app_country] => US
[patent_app_date] => 2021-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37413
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -52
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995191
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/995191 | INDOLE DITERPENE BIOSYNTHESIS | Mar 30, 2021 | Pending |
Array
(
[id] => 18311163
[patent_doc_number] => 20230115063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => BIOFILM ENHANCED TEXTILE AND METHODS FOR MANUFACTURING THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/913678
[patent_app_country] => US
[patent_app_date] => 2021-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6539
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17913678
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/913678 | BIOFILM ENHANCED TEXTILE AND METHODS FOR MANUFACTURING THEREOF | Mar 30, 2021 | Abandoned |
Array
(
[id] => 18753996
[patent_doc_number] => 20230357356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => RECOMBINANT FUSION PROTEIN FOR PREVENTING OR TREATING FIBROTIC DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/996202
[patent_app_country] => US
[patent_app_date] => 2021-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4846
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17996202
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/996202 | RECOMBINANT FUSION PROTEIN FOR PREVENTING OR TREATING FIBROTIC DISEASES | Mar 30, 2021 | Abandoned |
Array
(
[id] => 18363527
[patent_doc_number] => 20230145118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => Modified Red Blood Cells and Uses Thereof for Delivering Agents
[patent_app_type] => utility
[patent_app_number] => 17/906435
[patent_app_country] => US
[patent_app_date] => 2021-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19567
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17906435
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/906435 | Modified Red Blood Cells and Uses Thereof for Delivering Agents | Mar 18, 2021 | Pending |
Array
(
[id] => 18021034
[patent_doc_number] => 20220372533
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => TRANSGENIC MICROORGANISMS AND SYNTHESIS OF PIPERAZIC ACID, PIPERAZIC ACID CONTAINING PRODUCTS, AND DERIVATIVES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/203035
[patent_app_country] => US
[patent_app_date] => 2021-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21071
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -45
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17203035
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/203035 | Transgenic microorganisms and synthesis of piperazic acid, piperazic acid containing products, and derivatives thereof | Mar 15, 2021 | Issued |
Array
(
[id] => 20818725
[patent_doc_number] => 12674187
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-07-07
[patent_title] => Gram-positive bacteria of the species
[patent_app_type] => utility
[patent_app_number] => 17/908372
[patent_app_country] => US
[patent_app_date] => 2021-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 6972
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17908372
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/908372 | Gram-positive bacteria of the species | Mar 4, 2021 | Issued |
Array
(
[id] => 17067572
[patent_doc_number] => 20210269787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => HUMAN ALPHA-GALACTOSIDASE VARIANTS
[patent_app_type] => utility
[patent_app_number] => 17/186462
[patent_app_country] => US
[patent_app_date] => 2021-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43557
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17186462
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/186462 | HUMAN ALPHA-GALACTOSIDASE VARIANTS | Feb 25, 2021 | Abandoned |
Array
(
[id] => 20527435
[patent_doc_number] => 12545860
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-02-10
[patent_title] => Mannanase variants
[patent_app_type] => utility
[patent_app_number] => 17/798973
[patent_app_country] => US
[patent_app_date] => 2021-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23372
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17798973
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/798973 | Mannanase variants | Feb 11, 2021 | Issued |